Notably, mutations in genes related to microglial and macrophage activation, e.g. triggering receptor expressed on myeloid cells 2 (Trem2), a transmembrane receptor activated by Aβ [34] and associated with Aβ clearance [35,36], confer a relatively high risk of AD [37,38]. This evidence concerns the gene TREM2 and Alzheimer disease.